An Open-Labeled, Multi-Center, Randomized Investigation of the VISA (Comfilcon A) Silicone Hydrogel Soft (Hydrophilic) Contact Lens for Use in a 7 Day Extended Wear Regimen
An Open-Labeled, Multi-Center, Randomized Investigation of the VISA (Comfilcon A) Silicone Hydrogel Soft (Hydrophilic) Contact Lens for Use in a 7 Day Extended Wear Regimen
To compare the safety and efficacy of the CVI silicone-hydrogel lens worn on an extended wear basis for a period of up to 7 days and 6 nights with the Acuvue 2 soft contact lenses.
To compare the safety and efficacy of the CVI silicone-hydrogel lens worn on an extended wear basis for a period of up to 7 days and 6 nights with the Acuvue 2 soft contact lenses in this open-labeled randomized study.
Inclusion Criteria:
Exclusion Criteria:
Previously unsuccessful with contact lens wear.
Rigid gas permeable contact lens wear within the past 12 months.
Previous refractive surgery; current or previous orthokeratology treatment.
Subject is wearing lenses in a modified monovision modality (multifocal lens in one eye). NOTE: subjects may not wear monovision lenses at any time during the study unless they are wearing spherical monovision lenses prior to enrollment.
Aphakia, keratoconus or an irregular cornea.
A known history of corneal hypoesthesia
Clinically significant (grade 3 or 4) anterior segment abnormalities or any infection of the eye, lids, or associated structures.
Ocular or systemic disease or need for medication which might interfere with contact lens wear. i.e., Sjögren's syndrome, type II diabetes, etc.
Slit lamp findings that would contraindicate contact lens wear, including but not limited to:
Known sensitivity to the care systems used in this study.
Poor personal hygiene
Current pregnancy or is lactating (to the best of the subject's knowledge) or subject is planning pregnancy within the next 13 months.
Any active participation in another clinical study within 30 days prior to this study.
Subject is a member, relative or household member of the office staff, including the investigator(s).
Subjects must read, indicate understanding of, and sign the Informed Consent Form.